Japanese Scientists Turn Male Mouse Cells Into Fertile Females

The Y chromosome just got a lot less necessary.

A team at RIKEN and Yamanashi University has done something that conventional cloning never managed: they turned male mouse cells into females that can reproduce. The work, published on bioRxiv on August 4th, 2026, sounds like science fiction until you watch the mechanics. Then it sounds like science fiction with good engineering.

Here is what happened. The researchers took body cells — blood cells, in the adult-mouse experiments — from male mice. They used CRISPR-Cas9 to target the centromere, the structure that ensures chromosomes get properly divided when a cell splits. By cutting the centromere of the Y chromosome, they effectively disarmed it. During subsequent cell divisions, the Y chromosome could no longer be inherited and simply disappeared. The cell was now XO: one X chromosome, no Y. In mice, that combination produces a viable, fertile female. Not ideal, perhaps, but fully reproductive.

They then fed those modified cells into enucleated eggs via somatic cell nuclear transfer, the same technique behind Dolly the sheep and the northern white rhino clones that have appeared in conservation news over the past decade. Thirteen pups emerged from neonatal cell experiments. Ten were XO females. Seven-point-six percent efficiency on the first pass — not spectacular, but far above the baseline odds of random Y loss, which had produced only one accidental XO female out of twenty-seven clones in a 2009 Japanese study.

The experiment that gets repeated in every Western headline: a male mouse “giving birth” to his own daughter.

That image — a male donor mouse standing next to his cloned XO female offspring — is exactly what will circulate on social media. And yes, it is striking. The researchers mated the XO female back to her donor male and produced live offspring. In genetic terms, the daughter shared essentially all of her autosomal DNA with her father. Only the sex chromosome complement differed. It is biologically coherent and deeply unusual, which is why the study has already attracted commentary drawing parallels to the Adam-and-Eve narrative from the Book of Genesis.

But the headline-grabbing moment obscures what is actually significant about the paper: the team demonstrated that a single male mouse can now serve as the sole source of both male and female cloned offspring, and those two cloned lines can be bred together to produce a third generation.

That generational continuity matters more than the novelty of the first cross. The researchers also showed that blood cells frozen for one day and one month, then thawed and processed through Y-CUT and SCNT, produced the same result — exclusively XO females. Frozen genetic resources, long a fixture in zoological biodbanks, can now be converted into both sexes from a single male specimen.

The conservation angle that will be missed in most English coverage.

Western outlets will focus on the same-sex cloning angle and the theological echoes. The conservation implications deserve equal attention, and they are where the real practical stakes live.

Zoos and conservation programs around the world maintain frozen cell banks — the San Diego Zoo’s Frozen Zoo, for instance, holds samples from thousands of species. When a male individual of an endangered species dies, its preserved cells have traditionally yielded only male clones. That halves the usable genetic diversity from each sample. Y-CUT removes that constraint: a single male specimen can now generate both sexes, effectively doubling the reproductive potential encoded in a frozen sample.

The researchers explicitly cite this application. The wording matters — they do not claim the technique can resurrect extinct species or replace population-level breeding programs. What they describe is an expansion of the toolkit available to conservationalists who already rely on somatic cell nuclear transfer.

The species barrier that nobody will mention until it stops the project cold.

Mice are forgiving about missing a sex chromosome. Horses and humans are not. An XO individual in a horse — the case of the famous “Clone 1” who was mistakenly reported as a surviving XX mare when she was actually XO — develops but is sterile. The same applies to human Turner syndrome (XO), where affected individuals do not reach puberty without hormone therapy and cannot reproduce.

So Y-CUT will not let zoo biologists convert Przewalski’s horses from males into breeding females, no matter how impressive the mouse data looks. The method is a proof of principle for the general mechanism — targeted Y chromosome elimination via centromere disruption — but the downstream application depends entirely on whether the target species can sustain an XO genotype and still produce fertile offspring.

This is the distinction that tends to get flattened in reporting: a technique that works in one mammal does not automatically scale to another, even closely related ones. The paper acknowledges this plainly. The researchers note it as an open question rather than a limitation to hide.

What is actually new here, buried under the clickbait-ready imagery.

Three concrete advances distinguish this work from previous attempts at sex manipulation in clones.

First, Y-CUT is intentional and targeted. Earlier reports of XO females arising from male cell lines were treated as artifacts — rare errors in chromosome segregation. This study engineered the error deliberately and reproducibly. Seventy-seven percent of cloned offspring from neonatal cells came out XO female. That is not luck.

Second, the researchers showed it works in adult-derived somatic cells, not just newborn cells. Adult blood cells are easier to harvest from living donors without invasive procedures. One of the study’s composite images shows the original adult male mouse alive and well alongside his cloned offspring — a practical detail that will matter if this ever approaches non-laboratory applications.

Third, the third-generation viability was demonstrated. The cloned XO females produced normal XX daughters when mated with cloned XY males. The genetic line did not terminate at the sex-shifted generation. For conservation purposes, that continuity is the difference between a technical curiosity and a working protocol.

Why the method still falls short of the dramatic framing.

Even in mice, the technique requires three things that are not trivial to supply: enucleated oocytes from a female of the same or compatible species, and a surrogate mother to carry the pregnancy to term. One male cannot spontaneously start a breeding program. The starting point — the sole genetic donor — is what has changed. The rest of the reproductive infrastructure remains obligatory.

The safety data is also limited. Six XO females were examined for off-target genomic abnormalities, and none were found beyond the intended Y chromosome loss. The sample size is small. Larger-scale screening across more animals and more generations will be necessary before any confidence in genetic stability can be claimed.

The researchers themselves frame the achievement carefully. Ishii is quoted in the source material saying the work challenges the assumption that reproduction requires both a male and a female as distinct genetic contributors — not by eliminating the need for female reproductive biology, but by showing that the initial sex of the somatic donor need not determine the sex of the resulting organism.

That is a precise statement of what was actually accomplished. It is also, arguably, more interesting than the mythological parallels that will dominate the coverage. The biological mechanism is real. The scaling questions are unresolved. The conservation implications are partial but genuine. And the technique now exists in a form that other laboratories can reproduce, modify, and test against additional species.

The Y chromosome, it turns out, is not as immutable as textbooks have treated it — at least in mice.